Associations of Lymphocyte Subpopulations, Related Cytokines, Clinical Phenotypes, and Outcomes in Systemic Juvenile Idiopathic Arthritis
Issued Date
2025-08-01
Resource Type
eISSN
25785745
Scopus ID
2-s2.0-105011948601
Journal Title
Acr Open Rheumatology
Volume
7
Issue
8
Rights Holder(s)
SCOPUS
Bibliographic Citation
Acr Open Rheumatology Vol.7 No.8 (2025)
Suggested Citation
Lerkvaleekul B., Sitthisarunkul N., Apiwattanakul N., Klinmalai C., Pongsakul N., Vilaiyuk S. Associations of Lymphocyte Subpopulations, Related Cytokines, Clinical Phenotypes, and Outcomes in Systemic Juvenile Idiopathic Arthritis. Acr Open Rheumatology Vol.7 No.8 (2025). doi:10.1002/acr2.70070 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/111513
Title
Associations of Lymphocyte Subpopulations, Related Cytokines, Clinical Phenotypes, and Outcomes in Systemic Juvenile Idiopathic Arthritis
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
Objective: To facilitate appropriate management, we aimed to evaluate associations between lymphocyte subsets and related cytokines with clinical characteristics and treatment outcomes of patients with systemic juvenile idiopathic arthritis (sJIA). Methods: We collected blood samples from 53 patients with sJIA and evaluated the percentages of lymphocyte subsets and cytokine levels. Patients were categorized into active (n = 18), persistent (n = 11), and inactive (n = 24) sJIA groups based on clinical phenotypes. Seventeen patients with active disease provided longitudinal blood samples at 0, 4 to 6, and 24 weeks. Among these patients, 12 patients were classified as sJIA treatment responders (sJIA-R) and 5 patients were classified as sJIA treatment nonresponders (sJIA-NR). The healthy control (HC) group comprised 32 age-matched children. Results: Dynamic changes in lymphocyte subsets and cytokine levels were observed over time. In the longitudinal cohort, patients in the sJIA-R group showed a significant decline in proinflammatory cytokines, including interleukin-1 (IL-1), interferon-γ (IFN-γ), monocyte chemoattractant protein-1, and IL-23, along with increases in CD3<sup>+</sup>, CD4<sup>+</sup>, and CD8<sup>+</sup> T cells. In contrast, patients in the sJIA-NR group had persistently elevated IL-1, IL-23, and tumor necrosis factor levels and natural killer (NK) T cell percentages. Despite clinical improvement, IL-18 and IFN-γ levels remained elevated compared to HCs throughout the 24-week follow-up. Analysis of minor lymphocyte subsets revealed low NK and gamma delta (γδ) T cell percentages during active disease and follow-up. Notably, IL-23 levels and γδ T cell percentages were significantly associated with several disease activity parameters. Conclusion: Patients with sJIA exhibit altered lymphocyte subsets and inflammatory mediator production during the disease course, which may assist in identifying treatment responders and guiding therapeutic strategies. (Figure presented.) This study investigated associations of lymphocyte subpopulations, related cytokines, clinical phenotypes, and outcomes in systemic juvenile idiopathic (sJIA). Low percentages of NK and γδ-T cells were observed in patients with sJIA, particularly during active disease, compared to healthy controls. Persistent elevations in IL-1, IL-23, TNF, and NK T cell percentage were associated with poor treatment response.